Description

DUMAFIL CREAM is an advanced topical formulation engineered to support men experiencing premature ejaculation (PE) and performance anxiety during intimacy. This cream contains Lidocaine, a local anesthetic agent that temporarily reduces sensitivity on the penile surface, helping to prolong the duration of sexual intercourse by delaying ejaculation.

DUMAFIL CREAM is easy to apply, fast-absorbing, and specifically formulated to maintain efficacy without compromising safety or user comfort. By slightly numbing the nerve endings in the penis, it allows for greater control and improved sexual confidence, making it a preferred solution for men seeking a non-invasive and fast-acting approach to manage PE.

The product is designed for external use only and is typically applied 10 to 15 minutes prior to sexual activity. It is dermatologically tested, non-irritating, and compatible with most condom materials, ensuring practical use without interruption of sexual experience.

Manufactured in certified facilities that meet GMP and WHO-GMP standards, DUMAFIL CREAM is quality-assured, safe, and packaged for both retail and institutional markets. It can be produced in customizable tube sizes and branding formats, making it ideal for white-label and private-label clients targeting the sexual wellness market.

DUMAFIL CREAM is proudly represented by Bluepill Express, a leading Indian pharmaceutical company engaged in third-party manufacturing and global export of all types of medicines, including sexual health, men’s wellness, and topical treatment products. With a strong presence in international markets across Africa, Latin America, the Middle East, and Southeast Asia, Bluepill Express offers end-to-end support for regulatory documentation, logistics, and custom packaging.

As a reliable partner in the pharmaceutical export sector, Bluepill Express ensures that every unit of DUMAFIL CREAM meets stringent international quality standards, offering distributors and healthcare providers a powerful solution to expand their men’s health portfolio.